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Abstract
Introduction: Media sensationalism on the H1N1 outbreak may have influenced decisional processes and clinical
diagnosis.
Case Presentation: We report two cases of patients who presented in 2009 with coexisting H1N1 virus and
Legionella infections: a 69-year-old Caucasian man and a 71-year-old Caucasian woman. In our cases all the signs
and symptoms, including vomiting, progressive respiratory disease leading to respiratory failure, refractory
hypoxemia, leukopenia, lymphopenia, thrombocytopenia, and elevated levels of creatine kinase and hepatic
aminotransferases, were consistent with critical illness due to 2009 H1N1 virus infection. Other infectious disorders
may mimic H1N1 viral infection especially Legionnaires’ disease. Because the swine flu H1N1 pandemic occurred in
Autumn in Italy, Legionnaires disease was to be highly suspected since the peak incidence usually occurs in early
fall. We do think that our immediate suspicion of Legionella infection based on clinical history and X-ray
abnormalities was fundamental for a successful resolution.
Conclusion: Our two case reports suggest that patients with H1N1 should be screened for Legionella, which is not
currently common practice. This is particularly important since the signs and symptoms of both infections are
similar.
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Introduction
Media sensationalism with respect to the swine flu out-
break may have influenced decisional processes and
clinical diagnosis. We report two cases of patients who
present during 2009 in whom H1N1 and Legionella
infection coexisted. Secondary bacterial pneumonia is
recognized as one of the most common causes of death
in influenza cases. Coinfection has been found in 30% of
all influenza cases in persons with seasonal influenza.
The pathogens most often involved are Streptococcus
pneumoniae, Staphylococcus aureus, and Haemophilus
influenza [1,2]. From July 2009 through February 2010
in Italy, 2500 confirmed cases of pandemic influenza
and four and a half million cases of influenza-like ill-
nesses were reported to the sentinel surveillance system.
A total of 1278 (50%) confirmed cases of H1N1 were
hospitalized. Of these, 271 (21%) cases presented with
pneumonia, which was attributed to bacterial coinfec-
tion in 33 cases. Of the 33 cases with pneumonia due to
a bacterial coinfection, six (18%) were due to the Legio-
nella pneumophila serogroup 1 [3].
Case 1
Our first case is a 69-year-old Caucasian man with a
past medical history of coronary artery disease, chronic
renal insufficiency, hypertension and type 1 diabetes.
Two weeks earlier, he had been exposed to a child with
an upper respiratory infection. He lived in a rural area.
He had no history of insect bites, but was exposed to
farm animals and pond water.
He had been well until nine days earlier, when dry
cough, myalgias, fever (39.4°C), malaise, sore throat and
nasal congestion presented. On physical examination in
the Emergency Room (ER), the patient had a tempera-
ture of 39.2°C, a heart rate of 50 beats per minute and a
respiratory rate of 35 breaths per minute. A buccal swab
was negative for influenza A and B antigens, and no
parasites were seen on a peripheral-blood smear.
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Acetaminophen, ketorolac, levofloxacin and normal sal-
ine were administered.
After 24 hours he presented with persistent fever
(39.0°C), dry cough and respiratory failure and was
admitted to the intensive care unit (ICU). Vital signs
were as follows: blood pressure 135/70 mm Hg; heart
rate 50 beats per minute; respiratory rate 34 breaths per
minute; oxygen saturation 88%, on 50% inspired oxygen.
On physical examination rhonchi were detected in the
lower lung fields.
Repeated tests of nasopharyngeal secretions for influ-
enza viruses, parainfluenza virus, respiratory syncytial
virus, and adenovirus were negative. Testing for antibo-
dies to toxoplasma was suggestive of past infection. Cul-
tures of specimens of blood, urine, and sputum were
sterile. Polymerase chain reaction determination of buc-
cal swab for H1N1 influenza A virus was positive. Urin-
ary tests for Legionella antigens were positive.
On admission main laboratory examations were as fol-
lows: white blood cell count (WBC) was 9.8 K/mL (87%
neutrophils, 4% lymphocytes); C-reactive protein 205
mg/L; serum sodium 132 mEq/L; serum phosphorus 2.3
mg/dL; serum glutamate pyruvate transaminase (SGPT)
175 IU/L; serum oxaloacetate transaminase (SGOT) 184
IU/L; serum ferritin 4100 ng/mL; creatinine phosphoki-
nase (CPK) 241 IU/L. Winthrop scale score was > 15.
Chest radiograph showed low lung volumes, with
patchy air-space disease consistent with multifocal
pneumonia (Figure 1). Intravenous azithromycin (500
mg twice daily), levofloxacin (500 mg twice daily) and
oral oseltamivir (150 mg twice daily) were adminis-
tered. Within 18 hours after arrival, tachypnea and
hypoxemia (PaO2: 58 mm Hg, while breathing 50%
oxygen) increased further requiring intubation and
mechanical ventilation. Hypotension and renal failure
developed; methylprednisolone and vasopressors were
administered.
On the third day reverse transcriptasepolymerase
chain reaction (RT-PCR) on a broncoalveolar lavage
specimen was still positive for H1N1 influenza infection.
Legionella antigens were also confirmed positive. On the
fifth day he was extubated and non-invasive ventilation
was started. He was discharged from the ICU on day 21.
Case 2
Our second case is a 71-year-old Caucasian woman with
a past medical history significant for hypertension, type
1 diabetes and chronic hepatitis C.
She reported an eight day history of dry cough and
fever (39.2°C) associated with sore throat and nasal con-
gestion. She lived in a peripheral urban area. On emer-
gency room examination, her Glasgow Coma Score
(GCS) was 12 (E = 3 V = 4 M = 5), temperature was
39.6°C, blood pressure was 80/40 mm Hg, heart rate
was 54 beats per minute, respiratory rate was 40 breaths
per minute and oxygen saturation was 88% on 50%
inspired oxygen. Her chest radiograph was consistent
with multifocal pneumonia (Figure 1). There were
rhonchi in the left and right lung fields. A rapid test of
a specimen from a buccal swab was negative for influ-
enza A and B antigens, and no parasites were seen on a
peripheral-blood smear. Acetaminophen, ketorolac, levo-
floxacin and normal saline were administered.
After one hour she was admitted to the ICU and due
to worsening hypoxemia (PaO2 48 mm Hg, while
breathing 50% inspired oxygen), neurological impair-
ment with a GCS of 10 (E = 2 V = 3 M = 5) and hemo-
dynamic instability (blood pressure 80/40 mmHg, heart
rate 46 beats per minute), she was intubated and
mechanically ventilated. RT-PCR on a broncoalveolar
lavage specimen was positive for H1N1 influenza
infection.
On admission main laboratory examination results
were as follows: white blood cell (WBC) count was 5.8
Figure 1 Right panel: antero-posterior chest x-ray of patient 1. Left panel: antero-posterior chest x-ray of patient 2.
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K/Ml (77% neutrophils; 5% lymphocites); C-reactive pro-
tein was 312 mg/L; serum sodium was 129 mEq/L;
serum phosphorus was 2.5 mg/dL; serum SGPT were
215 UI/L; serum SGOT were 220 UI/L; serum ferritin
was 5280 ng/mL; CPK was 445 IU/L. Her Winthrop
scale score was > 15.
Intravenous levofloxacin (500 mg twice daily) and oral
oseltamivir (150 mg twice daily) were administered. On
the second day, hypoxemia, hypotension and renal fail-
ure developed; norepinephrine was administered after
fluid challenge. For persistent hypoxemia she was venti-
lated in the prone-supine position for 12 hour intervals
daily. Tests of the urine for legionella antigens were
positive. Azithromycin (500 mg twice daily) was added
her treatment.
On the ninth day she underwent percutaneous tra-
cheostomy. She was discharged from the ICU on day 35.
Discussion
During the Spring of 2009, a novel influenza A (H1N1)
virus of swine origin emerged to cause infections in
humans in North America [4].
The pandemic was carefully followed by the media but
with a touch of sensationalism that caused a widespread
a sense of fear in the population. Health care systems
and physicians were suddenly in the spotlight. In our
cases all the signs and symptoms (including respiratory
failure, refractory hypoxemia, leukopenia, lymphopenia,
thrombocytopenia, and elevated levels of creatine kinase
and hepatic aminotransferases) were consistent with cri-
tical illness due to infection with the 2009 H1N1 virus
[1,4,5].
Other infectious disorders may mimic H1N1 viral
infection especially Legionnaires’ disease. Because the
swine flu H1N1 pandemic occurred in Autumn in Italy,
Legionnaires’ disease was to be highly suspected since
its peak incidence usually occurs in early fall.
Initial attempts to diagnose H1N1 infection using
immunochromatography relied on test kits developed
for seasonal influenza A and B viruses, many of which
proved significantly less sensitive to H1N1. Hence, tests
with monoclonal antibodies that react with H1N1 but
not seasonal influenza A (H1N1 and H3N2) or B viruses
were developed.
Recognizing viral hemagglutinin and nucleoprotein,
specifically allows the detection of H1N1 virus in nasal
wash fluid or nasopharyngeal fluid from patients with
influenza-like illnesses.
Early and rapid diagnosis of H1N1-related respiratory
insufficiency needs rapid screening during a pandemic
but clinicians cannot rely only on the buccal swab test
and need to rule out false positive and negative cases by
RT-PCR on oral/nasal fluids or bronchoalveolar lavage
specimens.
In case one the visit by a child with an upper respira-
tory infection five days before the onset of illness in the
patient represents also a plausible exposure to the 2009
H1N1 virus; in case two the lack of positive anamnesis
for other suspicions together with the finding of positive
specimens for H1N1 influenza A infection could have
caused us arrive at a fashionable diagnosis and stopped
us from further investigations. We do think that the
immediate suspicion of Legionella infection based on
clinical history, X-ray abnormalities and Winthrop Uni-
versity Hospital Infectious Disease Division’s diagnostic
weighted point system scale (Table 1) were fundamental
for a successful resolution [6,7].
Almost all patients affected by pandemic H1N1 infec-
tions admitted to an ICU because of lung involvement
receive empiric antibiotic therapy. However, preliminary
clinical data have failed to demonstrate a consistent role
of bacterial co-infection suggesting that severe pulmon-
ary damage occurs as a result of viral pneumonia [1,11].
A recent autopsy study revealed evidence of concurrent
bacterial infection in 29% of cases [8]. In 45% of these
the pathogen was S. pneumoniae. These findings con-
firm the results of previous studies of autopsy specimens
showing that most deaths attributed to influenza A virus
occurred concurrently with bacterial pneumonia [9]. On
the other hand, they highlight the importance of treating
influenza patients with both empiric antibacterial ther-
apy and antiviral medications. According to our experi-
ence we believe that zoonotic infections had to be ruled
out. The lack of known contact with animals in an
immunocompetent host appears to rule out zoonotic
infections, such as Coxiella burnetii. One of the patients
had worked near water ponds, which could have been
contaminated by animal urine, but he did not have pul-
monary hemorrhage so leptospirosis seems unlikely.
Without exposure to birds, Chlamydia psittaci is unli-
kely. Community-acquired pneumonia (Streptococcus
pneumoniae, Haemophilus influenzae, S. pyogenes, or
Staphylococcus aureus) can cause severe pulmonary dis-
ease, especially in patients with antecedent influenza.
These pathogens should have responded to the broad-
spectrum antimicrobial therapy; therefore, they are unli-
kely to have been the sole cause of illness. Atypical bac-
terial pathogens such as Legionella pneumophila cause
multifocal pneumonia but usually do not cause upper
respiratory tract symptoms [1,2].
Anaplasmosis could result in a lower respiratory tract
disease but fulminant disease is rare and clinical improve-
ment should have occurred with levofloxacin treatment
[10]. Radiographic abnormalities also needed to be ruled
out. Many critically ill patients have radiographic findings
of viral pneumonitis, with bilateral interstitial and alveolar
infiltrates. Multifocal and patchy abnormalities as seen in
these patients have been reported in cases of 2009 H1N1
Iannuzzi et al. Journal of Medical Case Reports 2011, 5:520
http://www.jmedicalcasereports.com/content/5/1/520
Page 3 of 5
influenza A virus infection but do not completely rule out
invasive bacterial infection [2]. Ground glass opacity and
cavitary lobar opacity should focus attention on Legion-
naire’s disease [11].
Another potential contributory factor that needed to
be ruled out was viral infection of the respiratory tract.
Infection with adenovirus or influenza virus must be
considered. Adenovirus type 14 is the most likely cause
of severe viral pneumonia in adults. Radiographic find-
ings may include lobar infiltrates, although these are
more characteristic of bacterial pneumonia [12,13]. The
fact that bacterial infections should have responded to
levofloxacin argues against the fact that a secondary
bacterial pneumonia superimposed with influenza A or
B causing severe pulmonary disease. The lack of recent
travel in H5N1 (bird flu) endemic areas or exposure to
sick or dead poultry argue against H5N1 influenza (bird
flu) [14].
Conclusions
Our two case reports suggest that patients with H1N1
should be screened for Legionella, which is not currently
Table 1 Winthrop-University Hospital Infectious Disease Division’s diagnostic weighted point system for diagnosing
Legionnaires’ disease in adults (modified [15])
Presentation Point score
Clinical features
Temperature > 102 F* With relative bradycardia 5
Headache Active onset 2
Mental confusion/lethargy* Not drug-induced 4
Ear pain Acute onset 3
Nonexudative pharyngitis Acute onset 3
Hoarseness Acute not chronic 3
Sputum (purulent) Excluding AECB 3
Hemoptysis* Mild/moderate 3
Chest pain (pleuritic) 3
Loose stools/watery diarrhea* Not drug-induced 3
Abdominal pain* With/without diarrhea 2
Renal failure* Acute (not chronic) 3
Shock/hypotension* Excluding cardiac/pulmonary causes 5
Splenomegaly Excluding non-CAP causes 5
Lack of response to B-lactam antibiotics after 72 hours (excluding viral pneumonias) 5
Laboratory tests
Chest x-ray Rapidly progressive asymmetric infiltrates* (excluding severe influenza (human, avian, swine), HPS, SARS) 3
Severe hypoxemia with (A-a gradient (> 35)* Acute onset 2
Hyponatremia* Acute onset 1
Hypophosphatemia Acute onset 5
Elevated SGOT/SGPT (early/mild/transient)* Acute onset 2
Elevated Total bilirubin Acute onset 1
Elevated LDH (> 400)* Acute onset 5
Elevated CPK* Acute onset 4
Elevated CRP* Acute onset 5
Elevated Cold agglutinin titers (1:64) Acute onset 5
Relative lymphopenia (< 21%)* Acute onset 5
Elevated Ferritin (> 2 n)* 5
Microscopic hematuria* Excluding trauma, BPH, Foley catheter, bladder and/or renal neoplasms 2
Total point score Legionnaires’ Disease very likely > 15
Legionnaires’ Disease likely 5-15
Legionnaires’ Disease unlikely < 5
AECB, acute exacerbation of chronic bronchitis; BPH, benign prostatic hyperplasia; CPK, creatine phosphokinase; CRP, C-reactive protein; HPS, Hantavirus
pulmonary syndrome; LDH, lactate dehydrogenase; SARS, severe acute respiratory syndrome; SGOT/SGPT, serum glutamate oxaloacetate transaminase/serum
glutamate pyruvate transaminase; *otherwise unexplained (acute and associated with the pneumonia).
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common practice. This is particularly important since
the signs and symptoms of both infections are similar.
Doctors should never be dazzled by contingency and
media sensationalism in decision making. With prompt
identification of the bacterial etiology of pneumonia,
appropriate treatment can be started with both antibac-
terial therapy and antiviral medications. The length of
hospital stay and the mortality of both pandemic and
seasonal influenza can be reduced.
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